Clinical Trials Safety and Tolerability of Ranibizumab in Mono/Bilateral w-AMD Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye by ClinicalTrialsFeed • 2013/11/12 • 0 Comments Status: Not yet recruiting, Condition Summary: Wet Age Related Macular Degeneration Full Story →